BioCentury
ARTICLE | Clinical News

Feraheme ferumoxytol: Post-marketing study data

February 15, 2010 8:00 AM UTC

A safety update for IV Feraheme showed that 40 serious adverse events, including hypotension and anaphylactoid reactions, have been reported out of the estimated 35,000 patient exposures since the dru...